Vimarsana
Biggest News Aggregation in the World

Page 50 - Mark Mcclellan News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Mark Mcclellan. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Mark Mcclellan Today - Breaking & Trending Today

Patient, beware: Kansas and Missouri still pushing ineffective COVID antibody treatments - Vimarsana News

Patient, beware: Kansas and Missouri still pushing ineffective COVID antibody treatments

Many hospitals and clinics are still infusing the costly treatments — often charging hundreds of dollars a session — that public health officials now say are almost certainly useless.

Source: kmuw.org
Patient, beware: Kansas and Missouri still pushing ineffective COVID antibody treatments - Vimarsana News

Patient, beware: Kansas and Missouri still pushing ineffective COVID antibody treatments

Many hospitals and clinics are still infusing the costly treatments — often charging hundreds of dollars a session — that public health officials now say are almost certainly useless.

Source: kcur.org
Some states are still pushing an ineffective COVID antibody treatment - Vimarsana News

Some states are still pushing an ineffective COVID antibody treatment

The top 12 states using antibody therapies produced by Regeneron and Lilly, which research shows don’t work against omicron, include several Southern states with some of the lowest vaccination rates and California, which ranks among the top 20 for fully vaccinated residents.

Source: usf.edu
Florida Among States Still Pushing Ineffective Covid Antibody Treatments - Vimarsana News

Florida Among States Still Pushing Ineffective Covid Antibody Treatments

Unethically and deceptively, Florida is among states still pushing costly monoclonal treatments officials say are almost certainly useless.

Some states are still pushing an ineffective COVID antibody treatment - Vimarsana News

Some states are still pushing an ineffective COVID antibody treatment

The top 12 states using antibody therapies produced by Regeneron and Lilly, which research shows don’t work against omicron, include several Southern states with some of the lowest vaccination rates and California, which ranks among the top 20 for fully vaccinated residents.

Source: usf.edu